XARELTO (rivaroxaban) tablet https://gafacom.website/xarelto-rivaroxaban-tablet/ Medicines

XARELTO is a selective inhibitor of FXa. It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban inhibits free FXa and prothrombinase activity. Rivaroxaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, rivaroxaban decreases thrombin generation.

The post XARELTO (rivaroxaban) tablet first appeared on Gafacom.